September 24, 2018 — Corindus Vascular Robotics Inc. announced the first live transmission of a remote interventional procedure using the company’s CorPath platform was performed at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego on Sept. 22, 2018. The remote interventional procedure was broadcast live from Mayo Clinic to the TCT Main Arena. Utilizing CorPath GRX with developmental remote technology, combined with a telecommunications system to enable communication with the bedside staff, the operator at Mayo Clinic had the ability to remotely manipulate interventional devices within a porcine model's arteries while located in a different building.
The global shortage of skilled specialists who can treat emergent conditions, such as a heart attack or acute ischemic stroke, is significant and continues to be a growing problem. Remote treatment has the potential to enable physicians to conduct procedures from virtually any location, opening opportunities for more patients globally to receive the benefits of lifesaving procedures where minimizing time to treatment is critical.
Earlier this year, Mayo Clinic received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to support a multi-phase, multi-year development program for remote robotic technology. Mayo Clinic is working with Corindus to explore telerobotics as a new treatment paradigm that gives rural and underserved populations across the globe access to time-critical vascular therapies.
"We believe it fitting that the first-ever live transmission of a remote interventional procedure took place at the 30th anniversary of the TCT meeting. Interventional cardiovascular medicine has made great strides in the last 30 years, and this milestone case represents an important forward step as we advance the access and treatment of coronary artery and other vascular diseases," stated Martin Leon, M.D., founder of the Cardiovascular Research Foundation.
For more information: www.corindus.com
November 14, 2025 
